NGM Biopharmaceuticals, Inc. Free Cash Flow 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. free cash flow from 2019 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| NGM Biopharmaceuticals, Inc. Annual Free Cash Flow |
| 2023 |
-133.45 |
| 2022 |
-146.30 |
| 2021 |
-74.91 |
| 2020 |
-85.38 |
| 2019 |
-44.66 |
| 2018 |
-13.44 |
| 2017 |
-23.84 |
| NGM Biopharmaceuticals, Inc. Quarterly Free Cash Flow |
| 2023-12-31 |
-133.45 |
| 2023-09-30 |
-110.30 |
| 2023-06-30 |
-82.85 |
| 2023-03-31 |
-42.50 |
| 2022-12-31 |
-146.30 |
| 2022-09-30 |
-115.45 |
| 2022-06-30 |
-87.00 |
| 2022-03-31 |
-36.02 |
| 2021-12-31 |
-74.91 |
| 2021-09-30 |
-56.45 |
| 2021-06-30 |
-46.89 |
| 2021-03-31 |
-22.39 |
| 2020-12-31 |
-85.38 |
| 2020-09-30 |
-65.06 |
| 2020-06-30 |
-39.74 |
| 2020-03-31 |
-19.68 |
| 2019-12-31 |
-44.66 |
| 2019-09-30 |
-29.00 |
| 2019-06-30 |
-22.15 |
| 2019-03-31 |
-13.87 |
| 2018-12-31 |
-13.44 |
| 2018-09-30 |
-20.34 |
| 2018-06-30 |
-13.82 |
| 2018-03-31 |
-5.50 |
